Gontovnick L S, Ng S, Bellward G D
Can J Physiol Pharmacol. 1979 Nov;57(11):1238-45. doi: 10.1139/y79-187.
The present study was carried out to determine the effects of agents that influence benzo[a]pyrene (BP) metabolism in vitro on the irreversible binding of BP to rat hepatic macromolecules in vivo. The irreversible binding of [3H]BP was found to be both dose and time dependent after its intraperitoneal administration to male Wistar rats. The SKF 525-A, at doses of 50 and 75 mg/kg, ip 3 h before BP, decreased the level of binding from control by 31 and 34%, respectively. At 35 mg/kg, SKF-525-A had no effect. Diethyl maleate (0.6 mL/kg, ip) and cysteine (150 mg/kg, ip), 30 and 5 min before BP, respectively, did not alter the binding of BP from control. Oral methadone treatment, previously shown to increase selectively epoxide hydrase activity in male Wistar rats, also failed to alter the amount of BP bound to hepatic macromolecules. 3-Methylcholanthrene (20 mg/kg per day, ip, for 2 days) administered 24 h before BP, decreased the level of binding from control by 30%. Parallel in vitro studies were carried out with the various agents used in vivo.
本研究旨在确定体外影响苯并[a]芘(BP)代谢的试剂对其在体内与大鼠肝脏大分子不可逆结合的作用。给雄性Wistar大鼠腹腔注射[3H]BP后,发现其不可逆结合具有剂量和时间依赖性。在BP注射前3小时腹腔注射剂量为50和75mg/kg的SKF 525 - A,分别使结合水平比对照组降低了31%和34%。剂量为35mg/kg时,SKF - 525 - A无作用。分别在BP注射前30分钟和5分钟腹腔注射马来酸二乙酯(0.6mL/kg)和半胱氨酸(150mg/kg),未改变BP与对照组的结合。先前显示可选择性增加雄性Wistar大鼠环氧化物水解酶活性的口服美沙酮治疗,也未能改变与肝脏大分子结合的BP量。在BP注射前24小时腹腔注射3 - 甲基胆蒽(每天20mg/kg,共2天),使结合水平比对照组降低了30%。对体内使用的各种试剂进行了平行的体外研究。